Press Releases
Samsung Biologics embraces digitalization to provide next-level client satisfaction
Due to the ongoing spread of COVID-19, many countries have implemented entry and travel restrictions from other countries and strict regulations on direct interactions. As a result, a number of the bio industry's events and conferences have been canceled or postponed.
Amid this time of significant changes to market dynamics, Samsung Biologics has proactively responded to the shifting trends in 'digitalization' and the growing need for virtual connectivity.
Let's dive in to learn more about how Samsung Biologics embraced digital transformation as part of its unique strategy to provide next-level client satisfaction.
VIRTUAL EXHIBITION HALL
Samsung Biologics introduced its Virtual Exhibition Hall, coinciding with BIO International, one of the premier annual industry conferences in June 2020. Through an immersive and interactive experience enabled by photorealistic 3D modeling, visitors are able to view our business services and facilities, and have richer conversations with our team of experts. Our experiential platform was recognized for its highly interactive digital capabilities and virtual reality (VR) technology to connect with clients around the world, and won the Best Digital Campaign award for its ingenuity and creativity in the biopharma space during Digital Pharma Innovation Week.
Greater accessibility through digital optimization
Considering that many of our clients are based overseas, Samsung Biologics is committed to enhancing the convenience of the site visitors around the world. By leveraging a global cloud infrastructure with high-speed connectivity, this virtual platform ensures accessibility from anywhere and anytime, and provides an optimized environment on both PC and mobile.
Realistic spatial design creates life-like experience
Due to the COVID-19 pandemic halting all offline events, the Virtual Exhibition Hall recreates our exhibition booth to introduce our capabilities virtually to our clients and a wider-range of public audiences. The exhibition areas are segmented into three different sections based on each of the business units: DS & DP Contract Manufacturing (CMO), Contract Development (CDO), and Contract Testing services (CRO), offering convenience for clients and industry professionals with the resources they need. Throughout the experience, users can also request one-on-one meetings at the click of a button.
LIVE VIRTUAL TOUR (LVT)
On-site virtual inspections for clients and regulatory authorities are vital for biopharmaceutical companies as this often leads to a successful contract signing with major biotech companies. Samsung Biologics has also conducted dozens of inspections per year; however, on-site inspections and tours became difficult to conduct with the pandemic situation. Therefore, we've implemented the Live Virtual Tour (LVT) to allow for global clients to access our facilities via a live-streaming platform and take a scheduled tour, audit, or inspection at their convenience. The platform also leverages a global on-demand cloud infrastructure to optimize speed and connectivity for clients and regulatory bodies from any location.
Virtual Inspection
Samsung Biologics has the world's largest manufacturing capacity at a single site. Inspecting the facilities for cell culture, purification, material storage, and utilities requires a great deal of time. Through real-time, high-definition visual tours, clients and regulatory agencies are able to access our facilities from any location, along with documentation reviews. We've gained a tremendous amount of positive feedback from clients and regulatory agencies through this real-time virtual tour system while also supporting our teams to conduct inspections for authorizations more efficiently.
Secured Access, On Demand
In 2020, we implemented the Enterprise Quality Unified Information System (EQUIS), which integrated two separate systems—Enterprise Document Management System (EDMS) and Enterprise Quality Management System (EQMS)—into one. EQUIS allows our employees to manage quality records and documents in real-time on a single platform, ultimately improving cGMP record tracking, documentation, and assessment. As a cloud based system, EQUIS gives clients direct secure access to request, review, and approve documents and records related to their products on-demand.
As COVID-19 continues to cause significant shifts in people's lives, our ongoing efforts are to continuously invest in leading-edge technology platforms and digital innovation to ensure client satisfaction. Through this digital transformation, we are finding new ways to virtually connect with clients, regulatory bodies, and industry professionals. These innovative solutions not only drive enhanced client experience with efficiency and advanced mobility, but also position Samsung Biologics to advance the future of biopharma.
Due to the ongoing spread of COVID-19, many countries have implemented entry and travel restrictions from other countries and strict regulations on direct interactions. As a result, a number of the bio industry’s events and conferences have been canceled or postponed.
Amid this time of significant changes to market dynamics, Samsung Biologics has proactively responded to the shifting trends in ‘digitalization’ and the growing need for virtual connectivity.
Let’s dive in to learn more about how Samsung Biologics embraced digital transformation as part of its unique strategy to provide next-level client satisfaction.
VIRTUAL EXHIBITION HALL
Samsung Biologics introduced its Virtual Exhibition Hall, coinciding with BIO International, one of the premier annual industry conferences in June 2020. Through an immersive and interactive experience enabled by photorealistic 3D modeling, visitors are able to view our business services and facilities, and have richer conversations with our team of experts. Our experiential platform was recognized for its highly interactive digital capabilities and virtual reality (VR) technology to connect with clients around the world, and won the Best Digital Campaign award for its ingenuity and creativity in the biopharma space during Digital Pharma Innovation Week.
Greater accessibility through digital optimization
Considering that many of our clients are based overseas, Samsung Biologics is committed to enhancing the convenience of the site visitors around the world. By leveraging a global cloud infrastructure with high-speed connectivity, this virtual platform ensures accessibility from anywhere and anytime, and provides an optimized environment on both PC and mobile.
Realistic spatial design creates life-like experience
Due to the COVID-19 pandemic halting all offline events, the Virtual Exhibition Hall recreates our exhibition booth to introduce our capabilities virtually to our clients and a wider-range of public audiences. The exhibition areas are segmented into three different sections based on each of the business units: DS & DP Contract Manufacturing (CMO), Contract Development (CDO), and Contract Testing services (CRO), offering convenience for clients and industry professionals with the resources they need. Throughout the experience, users can also request one-on-one meetings at the click of a button.
LIVE VIRTUAL TOUR (LVT)
On-site virtual inspections for clients and regulatory authorities are vital for biopharmaceutical companies as this often leads to a successful contract signing with major biotech companies. Samsung Biologics has also conducted dozens of inspections per year; however, on-site inspections and tours became difficult to conduct with the pandemic situation. Therefore, we’ve implemented the Live Virtual Tour (LVT) to allow for global clients to access our facilities via a live-streaming platform and take a scheduled tour, audit, or inspection at their convenience. The platform also leverages a global on-demand cloud infrastructure to optimize speed and connectivity for clients and regulatory bodies from any location.
Virtual Inspection
Samsung Biologics has the world’s largest manufacturing capacity at a single site. Inspecting the facilities for cell culture, purification, material storage, and utilities requires a great deal of time. Through real-time, high-definition visual tours, clients and regulatory agencies are able to access our facilities from any location, along with documentation reviews. We’ve gained a tremendous amount of positive feedback from clients and regulatory agencies through this real-time virtual tour system while also supporting our teams to conduct inspections for authorizations more efficiently.
Secured Access, On Demand
In 2020, we implemented the Enterprise Quality Unified Information System (EQUIS), which integrated two separate systems—Enterprise Document Management System (EDMS) and Enterprise Quality Management System (EQMS)—into one. EQUIS allows our employees to manage quality records and documents in real-time on a single platform, ultimately improving cGMP record tracking, documentation, and assessment. As a cloud based system, EQUIS gives clients direct secure access to request, review, and approve documents and records related to their products on-demand.
As COVID-19 continues to cause significant shifts in people’s lives, our ongoing efforts are to continuously invest in leading-edge technology platforms and digital innovation to ensure client satisfaction. Through this digital transformation, we are finding new ways to virtually connect with clients, regulatory bodies, and industry professionals. These innovative solutions not only drive enhanced client experience with efficiency and advanced mobility, but also position Samsung Biologics to advance the future of biopharma.